CONNEQT Health Ltd
Conneqt Health has a liquidity risk with a debt-to-equity ratio of 5.79 and a current ratio of 0.9, indicating that the company's liabilities significantly outweigh its equity and that it may struggle to meet short-term obligations. The company's free cash flow is negative at -17.9 million AUD, and its operating cash flow is also negative at -10.9 million AUD, suggesting that the company is not generating sufficient cash from operations to sustain its activities. In terms of profitability, Conneqt Health is not performing well, with a return on equity of -28.72% and a return on assets of -1.95%. These figures are significantly below the industry norms for a company in the Advanced Medical Equipment & Technology industry, indicating that the company is not effectively utilizing its assets or equity to generate returns. The company's revenue is concentrated in a single business segment, as it operates in the digital health technology space with a focus on cardiovascular health monitoring. There is no disclosed geographic diversification in the financial snapshot, suggesting that the company's revenue is primarily derived from its operations in Australia. Conneqt Health's growth trajectory is not evident from the provided data, as the company reported a net loss of 18.2 million AUD and an operating loss of 12.8 million AUD. The company's revenue for the latest period is 3.55 million AUD, but there is no indication of growth or decline compared to previous periods. The company faces a medium liquidity risk, as indicated by the risk assessment, and the financial snapshot shows that the company has a negative net cash position after subtracting total debt. The dilution risk is assessed as low, and there are no adjustments applied in the custom valuations that would suggest a significant change in the company's capital structure. There are no recent events or filings mentioned in the provided data that would indicate significant changes in the company's operations or financial position. The company's financial performance and risk profile are based on the latest available financial data.
Business. Conneqt Health Limited develops and markets noninvasive patient monitoring technologies for assessing cardiovascular health, specializing in the SphygmoCor vascular biosensing technology to measure arterial health and provide clinical-grade arterial assessment.
Classification. Conneqt Health is classified in the Healthcare sector under the Advanced Medical Equipment & Technology industry with a confidence level of 0.92.
- Conneqt Health has a high debt-to-equity ratio and a low current ratio, indicating significant liquidity risk.
- The company is not profitable, with a negative return on equity and return on assets.
- Revenue is concentrated in a single business segment with no disclosed geographic diversification.
- The company's growth trajectory is unclear, with no indication of revenue growth or decline.
- The company has a medium liquidity risk and a low dilution risk.
- # RATIONALES
- {
- "margin_outlook_rationale": "The company's margin outlook is negative due to its high operating and net losses.",
- Net cash is negative after subtracting total debt.